C-erbB receptors in squamous cell carcinomas of the head and neck: Clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors

Oral Oncology

Volumn 38, Issue 1, 2002, Pages 73-80

  O charoenrat, P ^a   Rhys Evans, P H ^a   Archer, D J ^a   Eccles, S A ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

C erbB receptors; Epidermal growth factor receptor; Head and neck cancer; Matrix metalloproteinase; Squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

C ERBB RECEPTOR; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; ONCOPROTEIN; PROTEIN SUBUNIT; RECEPTOR SUBUNIT; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE C ERB; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036149083     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00029-X     Document Type: Article

References (31)

1. Squamous cell carcinoma of the head and neck: Past progress and future promise
2. Management of head and neck cancer in Britain
3. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling
4. Biochemical and clinical implications of the ErbB/HER signalling network of growth factor receptors
5. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
6. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
7. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
8. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands
9. Epidermal growth factor-like ligands differentially upregulate matrix metalloproteinase-9 in head and neck squamous carcinoma cells
10. Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells
11. Over-expression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
12. Expression and regulation of c-erbB ligands in human head and neck squamous carcinoma cells
13. Clinical relevance of erbB-1 and-2 oncogenes in oral carcinomas
14. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology
15. Correlations between MMPs and SA. MMPs and TIMP-1 with invasion and metastasis in head and neck squamous cell carcinomas
16. Mode of invasion: Bleomycin sensitivity and clinical course in squamous cell carcinoma of the oral cavity
17. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells
18. C-erb-B-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
19. Matrix metalloproteinases and oral cancer
20. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites increasing closely spaced PEA3/ets and AP-1 sequences
21. Growth factors in the regulation of pericellular proteolysis. A review
22. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways
23. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor
24. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
25. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity
26. Overexpression of the c-erb-B-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities
27. Heregulin and agonist anti-p185c-erbB2 antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpression p185c-erbB2: Increased invasiveness may contribute to poor prognosis
28. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
29. Regulation of angiogenesis via vascular endothelial growth factor receptors
30. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors